Stifel Financial
ADMA icon

Stifel Financial’s ADMA Biologics ADMA Stock Holding History

Stifel Financial’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$243K Sell
26,931
-2,988
-10% -$47.2K ﹤0.01% 3312
2025
Q4 		$546K Sell
29,919
-45,748
-60% -$771K ﹤0.01% 2808
2025
Q3 		$1.11M Buy
75,667
+15,605
+26% +$267K ﹤0.01% 2337
2025
Q2 		$1.09M Buy
+60,062
New +$1.22M ﹤0.01% 2274

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Stifel Financial's ADMA Position: Q1 2026 in Review

Stifel Financial reduced its ADMA Biologics (ADMA) stake by 10% in Q1 2026, selling an estimated $47.2K and leaving 26,931 shares worth $243K. The position accounts for ﹤0.01% of the portfolio, ranked #3312.

Stifel Financial first reported a position in ADMA in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.11M in Q3 2025. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • Stifel Financial held 26,931 shares of ADMA Biologics worth $243K as of Q1 2026.
  • Stifel Financial sold 2,988 ADMA Biologics shares in Q1 2026, an estimated $47.2K.
  • ADMA Biologics made up ﹤0.01% of Stifel Financial's portfolio in Q1 2026, its #3312 holding.
  • Stifel Financial first reported a position in ADMA Biologics in Q2 2025 and has held it in 4 quarters since.
  • Stifel Financial's ADMA Biologics position peaked at $1.11M in Q3 2025.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.